Mediastinal Grey Zone Lymphoma From the LYSA
NCT03037177 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99
Last updated 2017-01-31
Summary
Mediastinal grey zone lymphoma, B cell lymphomas with intermediate features between classical Hodgkin lymphoma and primary mediastinal B cell lymphoma, are not well described in the literature. Investigators report the clinical characteristics and outcomes of a large retrospective series of 99 cases centrally reviewed by a panel of hematopathologists, with a consensus established for the diagnosis.
Conditions
- Mediastinal Grey Zone Lymphoma
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-06-30
Countries
- France
Study Locations
More Related Trials
-
Exosomes and Immunotherapy in Non-Hodgkin B-cell Lymphomas
NCT03985696 ·Status: UNKNOWN ·Phase: NA
-
Study of the Pronostic Impact of Immunohistochemical, Histological and Radiological Factors in Patients With Primary Central Nervous System Lymphoma.
NCT05347511 ·Status: UNKNOWN
-
Multicenter Retrospective Observational Study of Relapsed Diffuse Large B-Cell Lymphoma Presenting as Indolent Lymphoma
NCT06822829 ·Status: RECRUITING
-
Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular)
NCT03859544 ·Status: UNKNOWN
-
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
NCT07121946 ·Status: RECRUITING ·Phase: PHASE1
-
Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade
NCT00551798 ·Status: COMPLETED ·Phase: NA
-
Low Grade Lymphoma
NCT01698866 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
NCT06806488 ·Status: RECRUITING
-
Characterisation of TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System Diffuse Large B Cell Lymphomas
NCT05133505 ·Status: COMPLETED
-
B-cell Chronic Lymphoid Malignancies Markers
NCT04952974 ·Status: UNKNOWN
-
Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study
NCT05162170 ·Status: COMPLETED
-
Refractory Diffuse Large B-cell Lymphoma
NCT03664336 ·Status: COMPLETED
-
PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE
NCT07313943 ·Status: RECRUITING
-
Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma
NCT04113226 ·Status: UNKNOWN ·Phase: PHASE2
-
ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma
NCT00144807 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma
NCT01202448 ·Status: COMPLETED ·Phase: NA
-
Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach
NCT07147751 ·Status: NOT_YET_RECRUITING
-
Clinical and Prognostic Value of Sarcopenia in Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma
NCT01715961 ·Status: COMPLETED ·Phase: NA
-
A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma
NCT01392716 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era
NCT00902434 ·Status: COMPLETED
-
Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS
NCT02339805 ·Status: COMPLETED ·Phase: NA
-
Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma
NCT07188077 ·Status: RECRUITING
-
An Italian Experience on Grade 3b Follicular Lymphoma
NCT02927717 ·Status: UNKNOWN
-
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
NCT05524298 ·Status: RECRUITING
-
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
NCT06024694 ·Status: ACTIVE_NOT_RECRUITING